Ovid Therapeutics (OVID) Prepaid Assets (2016 - 2026)
Ovid Therapeutics (OVID) posted Prepaid Assets of $4.6 million for Q1 2026, down 2.32% on a QoQ basis from $4.7 million in Q4 2025, and up 58.05% year-over-year from $2.9 million in Q1 2025.
Ovid Therapeutics (OVID) Prepaid Assets (2016 - 2026) Analysis & Trends
Ovid Therapeutics' Prepaid Assets history runs 11 years deep, the most recent figure standing at $4.6 million for Q1 2026.
- Quarterly Prepaid Assets rose 58.05% year-over-year to $4.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.6 million (up 58.05% YoY) and the FY2025 annual result came in at $4.7 million, up 65.2% from the prior year.
- Prepaid Assets was $4.6 million for Q1 2026 at Ovid Therapeutics, down from $4.7 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $5.7 million in Q2 2023 and bottomed at $1.8 million in Q1 2023.
- A 5-year average of $3.4 million and a median of $3.1 million in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2023 — Prepaid Assets jumped 108.22% — and 2024, when it tumbled 32.89%.
- Ovid Therapeutics' Prepaid Assets stood at $2.4 million in 2022, then soared by 58.16% to $3.8 million in 2023, then retreated by 23.86% to $2.9 million in 2024, then soared by 65.2% to $4.7 million in 2025, then decreased by 2.32% to $4.6 million in 2026.
- Business Quant data shows OVID's Prepaid Assets at $4.6 million in Q1 2026, $4.7 million in Q4 2025, and $3.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Ovid Therapeutics | 118.66 Mn | -36.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.62 Mn |
| Dec 31, 2025 | 4.73 Mn |
| Sep 30, 2025 | 3.22 Mn |
| Jun 30, 2025 | 3.74 Mn |
| Mar 31, 2025 | 2.93 Mn |
| Dec 31, 2024 | 2.87 Mn |
| Sep 30, 2024 | 3.12 Mn |
| Jun 30, 2024 | 3.92 Mn |
| Mar 31, 2024 | 2.91 Mn |
| Dec 31, 2023 | 3.76 Mn |
| Sep 30, 2023 | 4.64 Mn |
| Jun 30, 2023 | 5.65 Mn |
| Mar 31, 2023 | 1.80 Mn |
| Dec 31, 2022 | 2.38 Mn |
| Sep 30, 2022 | 2.64 Mn |
| Jun 30, 2022 | 2.72 Mn |
| Mar 31, 2022 | 2.42 Mn |
| Dec 31, 2021 | 2.68 Mn |
| Sep 30, 2021 | 3.28 Mn |
| Jun 30, 2021 | 3.71 Mn |